Medicus Pharma Rated 'Buy' with $12 Target by Brookline
Brookline initiates coverage on Medicus Pharma (MDCX) with a Buy rating and $12 target, highlighting innovative skin patch technology.
Topic
MDCX
A collection of 1 issue